Top 8 Foresite Capital Management Iv Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PHVS | Pharvaris N.V. | 56.94% | 4.78M | $135.0M | +0.00%(+0) | $24.90(+22.09%) | 2026-03-31 | |
| CYTK | CYTOKINETICS INC | 13.99% | 503.3K | $33.2M | +9.82%(+45.00K) | $45.85(+65.42%) | 2026-03-31 | |
| EIKN | Eikon Therapeutics, Inc. | 8.67% | 1.94M | $20.6M | new | $10.58(+25.24%) | 2026-03-31 | |
| LYEL | Lyell Immunopharma, Inc. | 6.77% | 800.4K | $16.1M | +0.00%(+0) | $174.57(-89.73%) | 2026-03-31 | |
| RLAY | Relay Therapeutics, Inc. | 4.2% | 1.00M | $9.9M | +0.00%(+0) | $6.80(+79.41%) | 2026-03-31 | |
| XENE | Xenon Pharmaceuticals Inc. | 3.92% | 160.0K | $9.3M | +0.00%(+0) | $32.78(+65.92%) | 2026-03-31 | |
| ALEC | Alector, Inc. | 3.53% | 3.89M | $8.4M | +0.00%(+0) | $2.26(-4.42%) | 2026-03-31 | |
| MAZE | Maze Therapeutics, Inc. | 1.98% | 156.9K | $4.7M | -69.98%(-365.76K) | $11.01(+132.15%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +18.31% | +65.61% |
| Top 20 Holdings Unweighted | +15.15% | +52.67% |
Sign up free to track Foresite Capital Management Iv Llc, compare funds side by side, and get alerts the moment positions change.